US$ 29.17
glp-1 weight loss drug news Seniors abandon weight-loss drugs over high costs and side effects Brain scientists are seeking weight-loss
Description
Manufacturers are seeking to improve efficacy by developing new dual- and tri-agonists, studying combinations, and offering more potent doses

Finally, although most of the included studies were of high quality, some trials had a potential risk of bias, such as open label design and pharmaceutical industry funding

Lean ME, Carraro R, Finer N, et al

Like, hey, I do need support
GLP-1 lowers postprandial glucose excursion by potentiating glucose-stimulated insulin secretion from pancreatic -cells and has also recently been shown to promote -cell survival in rodents 2
doi: 10.1177/25424823251388650
